Literature DB >> 31348535

Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18 F-FDG PET/CT.

Yuquan Zhang1,2, Chao Cheng3, Zhaobang Liu1,2, Lei Wang4, Guixia Pan3, Gaofeng Sun3, Yan Chang2, Changjing Zuo3, Xiaodong Yang2.   

Abstract

PURPOSE: To perform a radiomics analysis with comparisons of multidomain features and a variety of feature selection strategies and classifiers, with the goal of evaluating the value of quantified radiomics method for noninvasively differentiating autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC) in 18 F-fluorodeoxglucose positron emission tomography/computed tomography (18 F FDG PET/CT) images.
METHODS: We extracted 251 expert-designed features from 2D and 3D PET/CT images of 111 patients, and recombined these features into five feature sets according to their modalities and dimensions. Among the five feature sets, the optimal one was found leveraging four feature selection strategies and four machine learning classifiers based on the area under the receiver operating characteristic curve (AUC). The feature selection strategies include spearman's rank correlation coefficient, minimum redundancy maximum relevance, support vector machine recursive feature elimination (SVM-RFE), and no feature selection, while the classifiers are random forest, adaptive boosting, support vector machine (SVM) with the Gaussian radial basis function, and SVM with the linear kernel function respectively. Based on the optimal feature set, these feature selection strategies and classifiers were comparatively studied to achieve the best differentiation. Finally, the quantified radiomics prediction model was developed based on the best combination of the feature selection strategy and classifier, and it was compared with two clinical factors based prediction models, and human doctors using nested cross-validation in terms of AUC, accuracy, sensitivity, and specificity.
RESULTS: Comparison experiments demonstrated that CT features and three-dimensional (3D) features performed better than positron emission tomography (PET) features and three-dimensional (2D) features respectively, and multidomain features were superior to single domain features. In addition, the combination of SVM-RFE feature selection strategy and Linear SVM classifier had the highest diagnostic performance (i.e., AUC = 0.93 ± 0.01, ACC = 0.85 ± 0.02, SEN = 0.86 ± 0.03, SPE = 0.84 ± 0.03). The quantified radiomics model developed is significantly superior to both human doctors and clinical factors based prediction models in terms of accuracy and specificity.
CONCLUSIONS: Our preliminary results confirmed that the quantified radiomics method could aid the noninvasive differentiation of AIP and PDAC in 18 F FDG PET/CT images and the integration of multidomain features is beneficial for the differentiation.
© 2019 American Association of Physicists in Medicine.

Entities:  

Keywords:  18F FDG PET/CT; autoimmune pancreatitis; pancreatic ductal adenocarcinoma; radiomics

Mesh:

Substances:

Year:  2019        PMID: 31348535     DOI: 10.1002/mp.13733

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  18 in total

1.  Retrospective Analysis of the Value of Enhanced CT Radiomics Analysis in the Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis.

Authors:  Xi Ma; Yu-Rui Wang; Li-Yong Zhuo; Xiao-Ping Yin; Jia-Liang Ren; Cai-Ying Li; Li-Hong Xing; Tong-Tong Zheng
Journal:  Int J Gen Med       Date:  2022-01-06

Review 2.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

Review 3.  Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review.

Authors:  Gaowu Yan; Gaowen Yan; Hongwei Li; Hongwei Liang; Chen Peng; Anup Bhetuwal; Morgan A McClure; Yongmei Li; Guoqing Yang; Yong Li; Linwei Zhao; Xiaoping Fan
Journal:  Front Med (Lausanne)       Date:  2022-06-23

Review 4.  Pancreas image mining: a systematic review of radiomics.

Authors:  Bassam M Abunahel; Beau Pontre; Haribalan Kumar; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-11-05       Impact factor: 5.315

5.  Atypical enhanced computed tomography signs of pancreatic cancer and its differential diagnosis from autoimmune pancreatitis.

Authors:  Yong Zhao; Fei Li; Ning An; Zehua Peng
Journal:  Gland Surg       Date:  2021-01

Review 6.  Update on quantitative radiomics of pancreatic tumors.

Authors:  Mayur Virarkar; Vincenzo K Wong; Ajaykumar C Morani; Eric P Tamm; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2021-07-22

7.  Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP).

Authors:  Sebastian Ziegelmayer; Georgios Kaissis; Felix Harder; Friederike Jungmann; Tamara Müller; Marcus Makowski; Rickmer Braren
Journal:  J Clin Med       Date:  2020-12-11       Impact factor: 4.241

8.  Differentiation of Glioma Mimicking Encephalitis and Encephalitis Using Multiparametric MR-Based Deep Learning.

Authors:  Wenli Wu; Jiewen Li; Junyong Ye; Qi Wang; Wentao Zhang; Shengsheng Xu
Journal:  Front Oncol       Date:  2021-03-15       Impact factor: 6.244

9.  Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.

Authors:  Yan Deng; Bing Ming; Ting Zhou; Jia-Long Wu; Yong Chen; Pei Liu; Ju Zhang; Shi-Yong Zhang; Tian-Wu Chen; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

10.  Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis.

Authors:  Zhaobang Liu; Ming Li; Changjing Zuo; Zehong Yang; Xiaokai Yang; Shengnan Ren; Ye Peng; Gaofeng Sun; Jun Shen; Chao Cheng; Xiaodong Yang
Journal:  Eur Radiol       Date:  2021-03-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.